Header

Publications & News

Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies 29/04/2008

Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor 16/01/2008

Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study 22/05/2007

Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study 24/01/2007

Scil Technology Appoints New VP of Corporate Development 03/07/2006

Scil Technology Enrols First Patient in Phase II Sinus Lift Study 14/02/2006

Scil Technology Establishes Proof of Concept with Proprietary Cartilage Repair Technology 11/01/2006

Scil Technology Acquires Rights to Worldwide Patents for CD-RAP from Roche Diagnostics GmbH 10/10/2005

Scil Technology Initiates Preclinical Proof of Concept Study for Orthopaedic Project in Spinal Fusion 21/06/2005

Scil Technology Announces Positive Results in Preclinical Study of its Lead Dental Bone Augmentation Material 09/06/2005

Scil Technology Announces Update on MiraXion® 01/03/2005

Scil Technology Receives Renewal of GMP Certification for its analytical and Bioassay Laboratories 09/12/2004

Scil Technology Initiates Research into Cartilage Repair Using a Cartilage-Specific Growth Factor 01/12/2004

Scil Technology Announces Positive Results in Preclinical Proof-of-Concept Study for Orthopaedic Project in Spinal Fusion 18/11/2004

Scil Technology Files Patent on Coating Technology for Implants 05/05/2004

Scil Technology – a New German Biopharmaceutical Company – is Launched by the Scil Group Irina Staatz-Granzer is Named Managing Director 28/10/2003

Content End

Copyright 2009 Scil Technology GmbH. All rights reserved.